Indian Medtechs Call US Tariffs A Challenge To Growth And Seek Reciprocal Regulatory Access
Indian Medtech Firms Want Level Playing Field On Tariffs And Action On US Non-Tariffs Barriers
India’s medical technology industry is raising the alarm over steep new US tariffs on imported medical devices. It argues for structural change to address “unequal regulatory access” and non-tariff barriers.
